title: On the occurrence of hypomyelination in a transgenic mouse model:  a consequence of the myelin basic protein promoter?
abstract: Central nervous system hypomyelination is a feature common to a number of transgenic (Tg) mouse lines that express a variety of unrelated exogenous (i.e. non-central nervous system) transgenes. In this report, we document hypomyelination structurally by immunocytochemistry and functionally in the Tg line MBP-JE, which over expresses the chemokine CCL2 (MCP-1) within oligodendrocytes targeted by a myelin basic protein (MBP) promoter. Analysis of hypomyelinated optic nerves of Tg mice revealed progressive decrease in oligodendrocyte numbers with age (p < 0.01). Although molecular mechanisms underlying hypomyelination in this and other Tg models remain largely unknown, we present preliminary findings on oligodendrocyte progenitor cell (OPC) cultures in which, although OPC expressed CCR2, the receptor for CCL2, treatment with CCL2 had no significant effect on OPC proliferation, differentiation, or apoptosis. We suggest that hypomyelination in the MBP-JE model might not be due to CCL2 expression but rather the result of transcriptional dysfunction related to random insertion of the MBP promoter that disrupts myelinogenesis and leads to oligodendrocyte demise. Because an MBP promoter is a common denominator in most Tg lines displaying hypomyelination, we hypothesize that use of myelin gene sequences in the regulator region of Tg constructs might underlie this perturbation of myelination in such models.
authors.affiliation: Department of Pathology, Albert Einstein College of Medicine, Bronx, New York, USA.
authors.forename: Stefanie
authors.initials: S
authors.lastname: Gaupp
authors.forename: Joseph
authors.initials: J
authors.lastname: Arezzo
authors.forename: Dipankar J
authors.initials: DJ
authors.lastname: Dutta
authors.forename: Gareth R
authors.initials: GR
authors.lastname: John
authors.forename: Cedric S
authors.initials: CS
authors.lastname: Raine
mesh_terms: D000818:Animals; D003711:Demyelinating Diseases / Q000235:genetics*; D004195:Disease Models, Animal; D051379:Mice; D008822:Mice, Transgenic; D004676:Myelin Basic Protein / Q000235:genetics* / Q000378:metabolism; D009186:Myelin Sheath / Q000235:genetics* / Q000378:metabolism; D058953:Neural Stem Cells; D009836:Oligodendroglia / Q000378:metabolism*; D011401:Promoter Regions, Genetic
chemical_list: D004676:Myelin Basic Protein
references.citation: J Immunol. 2006 Nov 15;177(10):6871-9
references.pmid: 17082601
references.citation: J Neurobiol. 1998 Jan;34(1):10-26
references.pmid: 9469615
references.citation: J Immunol. 1995 Dec 15;155(12):5769-76
references.pmid: 7499865
references.citation: J Exp Med. 1996 Nov 1;184(5):1953-62
references.pmid: 8920882
references.citation: Neurochem Res. 1999 Sep;24(9):1181-8
references.pmid: 10485590
references.citation: Nature. 1978 Sep 28;275(5678):326-7
references.pmid: 692713
references.citation: J Immunol. 2009 Oct 1;183(7):4229-40
references.pmid: 19734214
references.citation: J Neurosci. 2007 Dec 26;27(52):14375-82
references.pmid: 18160645
references.citation: J Immunol. 2002 Feb 1;168(3):1009-17
references.pmid: 11801633
references.citation: Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19162-7
references.pmid: 19855010
references.citation: Neuron. 2002 Nov 14;36(4):585-96
references.pmid: 12441049
references.citation: J Neurosci. 2003 Jul 2;23(13):5561-71
references.pmid: 12843257
references.citation: Neuron. 2004 Jul 22;43(2):183-91
references.pmid: 15260955
references.citation: Brain Res. 1979 Oct 5;174(2):283-308
references.pmid: 385109
references.citation: Lab Invest. 1988 May;58(5):484-502
references.pmid: 3285096
references.citation: J Cell Biol. 1998 Feb 23;140(4):925-34
references.pmid: 9472043
references.citation: J Neurosci. 2000 Oct 15;20(20):7698-705
references.pmid: 11027231
references.citation: J Exp Med. 2003 Jul 21;198(2):305-13
references.pmid: 12874263
references.citation: J Neurobiol. 2001 Nov 15;49(3):224-34
references.pmid: 11745660
references.citation: Neuron. 2005 Sep 1;47(5):681-94
references.pmid: 16129398
references.citation: J Immunol. 2003 Mar 15;170(6):2843-52
references.pmid: 12626534
references.citation: J Neurosci. 1987 Sep;7(9):2737-44
references.pmid: 3305800
references.citation: Brain. 1999 Dec;122 ( Pt 12):2279-95
references.pmid: 10581222
references.citation: J Neurosci. 2006 Nov 22;26(47):12174-85
references.pmid: 17122042
references.citation: J Neurosci Res. 1996 Apr 15;44(2):165-73
references.pmid: 8723225
references.citation: J Exp Med. 2001 Mar 19;193(6):713-26
references.pmid: 11257138
references.citation: Brain. 2006 Jan;129(Pt 1):212-23
references.pmid: 16230319
references.citation: Am J Pathol. 2009 Jan;174(1):164-76
references.pmid: 19095949
references.citation: Nat Med. 2002 Oct;8(10):1115-21
references.pmid: 12357247
references.citation: J Exp Med. 2000 Sep 18;192(6):899-905
references.pmid: 10993920
references.citation: J Neurosci. 1994 Jan;14(1):198-207
references.pmid: 7506762
references.citation: J Cell Biol. 1992 Nov;119(3):605-16
references.pmid: 1383235
references.citation: J Neuroimmunol. 2006 Jul;176(1-2):162-73
references.pmid: 16753227
references.citation: Nat Neurosci. 2009 Nov;12(11):1398-406
references.pmid: 19838178
references.citation: Genes Brain Behav. 2008 Mar;7(2):203-13
references.pmid: 17640289
references.citation: Nature. 1991 Oct 10;353(6344):566-9
references.pmid: 1717849
references.citation: Am J Pathol. 1999 Jan;154(1):45-51
references.pmid: 9916917
references.citation: Science. 2004 Dec 17;306(5704):2111-5
references.pmid: 15604411
references.citation: Dev Neurosci. 1995;17(3):127-36
references.pmid: 8549424
references.citation: Am J Pathol. 2003 Jan;162(1):139-50
references.pmid: 12507897
references.citation: Nat Med. 2001 Feb;7(2):161-6
references.pmid: 11175845